Mary Hobart
Mary Hobart publishes mostly in Psychiatry and Mental health, Pharmacology and Clinical Psychology, on topics such as Treatment of Major Depression, Schizophrenia research and treatment and Healthcare Decision-Making and Restraints.
- World rank
- #519,239 of 7,710,434 ranked researchers
- Rank in Denmark
- #3,876 of 43,819
- Works
- 65
- Citations
- 2.3k
- Citations per work
- 35.2
What does Mary Hobart research?
Mary Hobart's work is mostly in Medicine (49%), Psychology (20%), Neuroscience (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3248.9%
- Medicine3248.9%
- Social Sciences1523.4%
- Psychology1319.5%
- Arts and Humanities33.9%
- Everything else1422.1%
- Life Sciences45.6%
- Neuroscience45.6%
- 1Psychiatry and Mental health32% of their works
- 2Pharmacology17% of their works
- 3Clinical Psychology16% of their works
- 4Cellular and Molecular Neuroscience6% of their works
- 5Experimental and Cognitive Psychology4% of their works
- 6Philosophy4% of their works
Research topics
- Treatment of Major Depression
- Schizophrenia research and treatment
- Healthcare Decision-Making and Restraints
- Neurotransmitter Receptor Influence on Behavior
- Dementia and Cognitive Impairment Research
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Mary Hobart's research?
The keywords of their largest research topics: Antidepressant, Depression, Antipsychotic Drugs, Neurocognitive Deficits, Neurobiology, Neuroimaging, Prevalence and Informed Consent.
- Cost-effectiveness Analysis
- Mild Cognitive Impairment
- Attention-Deficit/Hyperactivity Disorder
- ADHD
- Dopamine
- Informed Consent
- Neuroimaging
- Neurocognitive Deficits
- Depression
- Antidepressant
- Antipsychotic Drugs
- Neurobiology
- Prevalence
- Psychiatric Treatment
- Serotonin
- Alzheimer's Disease
- Bipolar Spectrum Disorder
- Treatment Guidelines
- Quality of Life
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Antidepressant301 topic
- Depression301 topic
- Antipsychotic Drugs271 topic
- Neurocognitive Deficits271 topic
- Neurobiology182 topics
- Neuroimaging182 topics
- Prevalence182 topics
- Informed Consent121 topic
- Psychiatric Treatment121 topic
- Dopamine101 topic
- Serotonin101 topic
- ADHD91 topic
- Alzheimer's Disease91 topic
- Attention-Deficit/Hyperactivity Disorder91 topic
- Bipolar Spectrum Disorder91 topic
- Mild Cognitive Impairment91 topic
- Treatment Guidelines91 topic
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
Where does Mary Hobart work?
Mary Hobart's main affiliation in the publication record is Lundbeck (Denmark), Denmark.
How many publications and citations does Mary Hobart have?
OpenAlex counts 65 works and 2,285 citations for Mary Hobart, an h-index of 22, ranking #519,239 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mary Hobart. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.